Efficacy of idebenone in Duchenne muscular dystrophy

Affiliations

¹ Pediatric Neurology Unit, Catholic University, Policlinico Gemelli, Rome 00168, Italy. Electronic address: mercuri@rm.unicatt.it.
² Dubowitz Neuromuscular Centre and MRC Centre for Neuromuscular Diseases, UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.

Comment

Eugenio Mercuri et al. Lancet. 2015.

. 2015 May 2;385(9979):1704-1706.

doi: 10.1016/S0140-6736(15)60758-9. Epub 2015 Apr 20.

¹ Pediatric Neurology Unit, Catholic University, Policlinico Gemelli, Rome 00168, Italy. Electronic address: mercuri@rm.unicatt.it.
² Dubowitz Neuromuscular Centre and MRC Centre for Neuromuscular Diseases, UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.

No abstract available

Comment on

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial.
Buyse GM, Voit T, Schara U, Straathof CSM, D'Angelo MG, Bernert G, Cuisset JM, Finkel RS, Goemans N, McDonald CM, Rummey C, Meier T; DELOS Study Group. Buyse GM, et al. Lancet. 2015 May 2;385(9979):1748-1757. doi: 10.1016/S0140-6736(15)60025-3. Epub 2015 Apr 20. Lancet. 2015. PMID: 25907158 Clinical Trial.